Stock AVCN AVICANNA INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Avicanna Inc.

Equities

AVCN

CA05368K1003

Delayed Toronto S.E.
Other stock markets
 19:45:06 16/05/2024 BST 		5-day change 1st Jan Change
0.34 CAD -6.85% Intraday chart for Avicanna Inc. +7.94% -2.86%
05-14 Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History MT
05-14 Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History
MT
Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History
MT
Avicanna Brief: Record Q1 revenue of $6.45 million representing a year-over-year increase of 451% compared to Q1 2023
MT
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
AQ
Avicanna Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Avicanna Announced Results of Study in Patients with Epidermolysis Bullosa
MT
Avicanna Brief: Announcing Results of Study in Patients with Epidermolysis Bullosa
MT
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
AQ
Avicanna Raises About $2.1 Million in Non-brokered Private Placement
MT
Avicanna Announces Closing of Non-brokered Private Placement
AQ
Avicanna Inc. announced that it has received CAD 2.125584 million in funding
CI
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
AQ
Avicanna Inc. Announces Completion of Topical Gel Observational Real-World Evidence Study
CI
Transcript : Avicanna Inc., 2023 Earnings Call, Apr 02, 2024
Avicanna's Q4 Loss Narrows, Revenue Grows
MT
Avicanna Brief: Reporting $16.8 Million in 2023 Revenue, representing an increase of 314% from 2022
MT
Avicanna Reports Full Year 2023 Audited Financial Results 
AQ
Avicanna Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Avicanna Announced Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
MT
Avicanna Brief: Announcing Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVCN Stock
  4. News Avicanna Inc.